Intended use:The RIDA qLine® autoBlot is a stand alone analyzer for the automated performance of up to 36 RIDA qLine® Allergy membranes in one run. All steps like the detection of the samples by [...]
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
We complement our control reagent portfolio with new controls including SARS-CoV2 positive and negative controls, as well as all-encompassing validation and verification kits for respiratory and [...]
As allergies become more widespread, their diagnosis takes on an important role. For this purpose, laboratory tests that detect allergen-specific antibodies in the blood are indispensable tools. [...]
R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the [...]
All RIDA®GENE SARS CoV-2 tests detect the new variant Omicron (B1.1.529) with the usual sensitivity and reliability
The Omicron variant does not show any mutations in the areas detected by our assays and is therefore positively detected by RIDA®GENE SARS-CoV-2 (Art. No. PG6815/ PG6820) and RIDA®GENE Flu & [...]
R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a very economic and easy handling.